Aims and Scope

The aim of the Journal of Clinical Practice and Cancer Research is to advance the understanding, prevention, diagnosis, and treatment of cancer through the publication of cutting-edge, high-quality, and peer-reviewed research. The journal seeks to serve as a global platform for disseminating critical knowledge in oncology, fostering collaboration between scientists, clinicians, and other healthcare professionals. By publishing groundbreaking research, clinical trials, and innovative therapies, the journal aims to contribute to improved cancer care and outcomes worldwide.

The mission of the Journal of Clinical Practice and Cancer Research is to advance the global understanding of cancer through the publication of high-impact research and clinical insights that can be directly applied to patient care. The journal strives to foster collaboration between basic scientists, clinical researchers, oncologists, and healthcare practitioners to accelerate the translation of laboratory findings into clinical applications. The Journal of Clinical Practice and Cancer Research is committed to promoting innovation in cancer research and treatment while ensuring that patients’ needs remain at the heart of this scientific progress.

The main Goal of the Journal is to establish a premier platform for disseminating innovative and transformative cancer research that enhances our comprehension of cancer biology and its intricacies.

To showcase studies that advance new cancer therapies in clinical settings, including groundbreaking drug discoveries, personalized medicine strategies, immunotherapies, and combination therapies.
To foster collaboration among researchers from various disciplines—such as oncology, genomics, bioinformatics, immunology, and healthcare professionals—promoting significant advancements in cancer treatment.
To equip clinicians with the most recent research findings, trial results, and treatment innovations that can significantly influence patient outcomes and enhance cancer care practices on a global scale.
To aid in the creation of more effective screening methods and preventive measures, concentrating on the early detection of cancer at stages that are more amenable to treatment and aiming to lower cancer incidence rates.
To tackle the worldwide cancer challenge, ensuring that cancer research is accessible to clinicians and researchers everywhere, particularly in resource-limited environments, while advocating for equitable cancer care.
To maintain the highest ethical standards in cancer research and clinical practice, offering a platform for discussing ethical dilemmas in research and patient care.
To highlight the significance of patient quality of life and survivorship, encouraging research that promotes comprehensive cancer care from diagnosis through treatment and into post-treatment support.

By establishing clear and ambitious goals, the Cancer Research Journal will strive to become a premier publication that not only disseminates scientific findings but also plays an active role in shaping the future of cancer research and care globally.

Scope:

The Journal of Clinical Practice and Cancer Research encompasses a broad and interdisciplinary range of topics relevant to cancer research and clinical practice.

The journal will cover, but is not limited to, the following areas:

Immunotherapy	Checkpoint Inhibitors	Immunomodulation	Proton Therapy
Cancer Survivorship	Chemoprevention	Immunotherapy Clinical Trials	Psychosocial Support for Cancer Patients
Nanotechnology	Chromatin Remodeling	Inflammation in the Tumor Microenvironment	Public Health and Cancer
Precision Medicine	Chronic Inflammation and Cancer	Inflammation in TME	Quality of Life in Cancer Survivors
Access to Cancer Treatment	Circulating Tumor Cells (CTCs)	Inflammatory Pathways	Radiation-Induced DNA Damage
Adaptive Clinical Trials	Clonogenicity	Lifestyle Modifications	Radiogenomics
Adaptive Treatment Strategies	Combination Therapy Trials	Liquid Biopsy	Radiomics
Adoptive Cell Transfer	Cytokine Networks	Liquid Biopsy for Early Detection	Radiotherapy and Imaging
Age-Related Cancer Risk Factors	DNA Methylation	Long-Term Cancer Survivorship	Regenerative Oncology
Aging-Related Cancer Pathways	Early Cancer Detection Tests	Lymphatic Spread	Screening Programs
AI in Drug Discovery	Early Detection and Screening	Machine Learning in Oncology	Self-Renewal Properties
AI in Radiology	EGFR Inhibitors	Medical Imaging (MRI, PET, CT)	Senescence and Cancer
AI-Powered Diagnostics	Epigenetic Drugs	Metastasis	Small Molecule Inhibitors
Angiogenesis	Epigenetic Reprogramming	Microbiome and Cancer	Smoking Cessation and Cancer Risk
Angiogenesis and TME	Epigenetics	Microbiome-Immune Interaction	Somatic Mutations
Artificial Intelligence (AI) and Big Data	Epigenetics of Aging and Cancer	Monoclonal Antibodies	Stem Cell Markers
Big Data in Cancer Research	Exome Sequencing	Mutational Landscape	Stem Cell Therapy
Biomarker-Driven Trials	Exosome Therapy	Nanomedicine	Stereotactic Radiosurgery
Biomarkers	Exosome-Mediated Metastasis	Nanoparticle Carriers for Chemotherapy	Targeted Therapy
BRAF Inhibitors	Extracellular Matrix	Nanoparticle Drug Delivery	Therapeutic Target Identification
Cancer and Aging	Fibroblasts and Cancer	Nanoparticle-Enhanced Imaging	Therapy Resistance
Cancer and Inflammation	Gene Editing (CRISPR/Cas9)	Nanotheranostics	Tissue Engineering in Cancer
Cancer and the Microbiome	Gene Therapy	NF-kB Pathway	Tumor Invasion
Cancer Cell Migration	Genetic Screening	Non-coding RNAs (ncRNA)	Tumor Microenvironment (TME)
Cancer Clinical Trials	Genomic Profiling	Non-invasive Diagnostics	Tumor Profiling
Cancer Epidemiology	Global Cancer Burden	Nutritional Oncology	Tumor Stroma
Cancer Genome Atlas (TCGA)	Global Cancer Initiatives	Oncogenes	Tumor Suppressor Genes
Cancer Genomics	Global Cancer Trials	Oncolytic Viruses	Tumor-Associated Microbiome
Cancer Healthcare Disparities	Gold Nanoparticles in Cancer	Palliative Care	Tumorigenesis
Cancer in Low-Resource Settings	Gut Microbiome	Patient-Specific Treatment	Tyrosine Kinase Inhibitors (TKIs)
Cancer Prevention	Histone Modification	Personalized Medicine	Vaccine Development
Cancer Stem Cell Niche	Hormonal Therapy for Prevention	Pharmacogenomics
Cancer Stem Cells	Hypoxia in Tumors	Phase I/II/III Clinical Trials
Cancer Vaccines	Image-Guided Radiation Therapy (IGRT)	Post-Treatment Care
CAR-T Cell Therapy	Immune Checkpoint Blockade	Predictive Models in Cancer
Cell Therapy and Regenerative Medicine	Immune Evasion	Probiotics and Cancer

Research Text Publishers

Journal of Clinical Practice and Cancer Research

Aims and Scope